LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Search

iRhythm Technologies Inc

Отворен

СекторЗдравеопазване

187.22 0.41

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

183.21

Максимум

187.95

Ключови измерители

By Trading Economics

Приходи

9M

-5.2M

Продажби

6.2M

193M

Марж на печалбата

-2.702

Служители

2,000

EBITDA

7.7M

2.4M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+17.66% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

33M

5.9B

Предишно отваряне

186.81

Предишно затваряне

187.22

Настроения в новините

By Acuity

19%

81%

31 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

iRhythm Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.11.2025 г., 16:49 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse in Talks to Buy Fund-Tech Platform Allfunds in $6 Billion Deal

27.11.2025 г., 15:32 ч. UTC

Придобивния, сливания и поглъщания

TotalEnergies, Repsol in Talks to Combine U.K. North Sea Assets, Cinco Dias Says, Citing Sources

27.11.2025 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Trade Rangebound Amid Caution Over Economic Outlook -- Market Talk

27.11.2025 г., 23:50 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

27.11.2025 г., 16:05 ч. UTC

Пазарно говорене

Canadian Job Vacancies Rise for Fist Time Since Start of 2024 -- Market Talk

27.11.2025 г., 16:04 ч. UTC

Пазарно говорене

Canadian Payroll Employment Pulls Back in September, Offsetting Recent Gains -- Market Talk

27.11.2025 г., 15:54 ч. UTC

Придобивния, сливания и поглъщания

Allfunds Shares Rise 21% After Deutsche Boerse Says Started Acquisition Talks

27.11.2025 г., 15:44 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse: No Certainty Talks Will Result in Transaction

27.11.2025 г., 15:43 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse: Allfunds Board of Directors Has Agreed to Enter Exclusive Talks

27.11.2025 г., 15:42 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse: Nonbinding Proposal is To Acquire Allfunds at EUR8.80 a Share

27.11.2025 г., 15:41 ч. UTC

Придобивния, сливания и поглъщания

Deutsche Boerse in Talks With Allfunds on Possible Acquisition

27.11.2025 г., 15:11 ч. UTC

Пазарно говорене

Dollar Could Fall in 2026 as U.S. Rate Cuts Bite -- Market Talk

27.11.2025 г., 14:26 ч. UTC

Пазарно говорене

Hermes' Outperformance Gap Could Narrow -- Market Talk

27.11.2025 г., 14:11 ч. UTC

Пазарно говорене

Lack of Major Budget Surprises Don't Justify Continued Sterling Strength -- Market Talk

27.11.2025 г., 14:11 ч. UTC

Пазарно говорене

Market Talk Roundup: Latest on U.S. Politics

27.11.2025 г., 13:35 ч. UTC

Пазарно говорене

Richemont Looks Set to Continue Outgrowing Peers -- Market Talk

27.11.2025 г., 13:33 ч. UTC

Пазарно говорене

Sterling's Post-Budget Gains Are Probably Over -- Market Talk

27.11.2025 г., 13:22 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

27.11.2025 г., 13:22 ч. UTC

Пазарно говорене

Kering's Plan to Revive Gucci Needs More Clarity -- Market Talk

27.11.2025 г., 13:17 ч. UTC

Пазарно говорене

LVMH Should Be Able to Recover Next Year -- Market Talk

27.11.2025 г., 11:13 ч. UTC

Пазарно говорене

European Gas Prices Come Under Pressure -- Market Talk

27.11.2025 г., 11:07 ч. UTC

Печалби

Genting: Positive About Prospects Over Longer Term

27.11.2025 г., 11:06 ч. UTC

Печалби

Genting: Cautious on Near-Term Prospects of Leisure, Hospitality Industry

27.11.2025 г., 11:04 ч. UTC

Печалби

Genting: International Travel Demand Expected to Remain Resilient

27.11.2025 г., 11:04 ч. UTC

Печалби

Genting: Global Growth Expected to Remain Subdued

27.11.2025 г., 11:04 ч. UTC

Печалби

Genting: Ebitda Partly Weighed by Stronger Ringgit Vs. Singapore Dollar, British Pound, U.S. Dollar

27.11.2025 г., 10:59 ч. UTC

Печалби

Genting Bhd 3Q Net Profit Fell 86% on Year

27.11.2025 г., 10:58 ч. UTC

Печалби

Genting Bhd 3Q Rev Rose 14% on Year

27.11.2025 г., 10:56 ч. UTC

Печалби

Genting Bhd 3Q Net MYR30.3M

27.11.2025 г., 10:56 ч. UTC

Печалби

Genting Bhd 3Q EPS MYR0.0079

Сравнение с други в отрасъла

Ценова промяна

iRhythm Technologies Inc Прогноза

Ценова цел

By TipRanks

17.66% нагоре

12-месечна прогноза

Среден 219.62 USD  17.66%

Висок 244 USD

Нисък 185 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за iRhythm Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

12

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

104.78 / 137.91Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

31 / 374 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat